Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
Abstract In the present study, we demonstrated the emergence of dalbavancin non-susceptible and teicoplanin-resistant Staphylococcus aureus small colony variants which were selected in vivo through long-term treatment with dalbavancin. A 36-year-old man presented with a cardiac device-related S. aur...
Main Authors: | Manuel Kussmann, Matthias Karer, Markus Obermueller, Katy Schmidt, Wolfgang Barousch, Doris Moser, Marion Nehr, Michael Ramharter, Wolfgang Poeppl, Athanasios Makristathis, Stefan Winkler, Florian Thalhammer, Heinz Burgmann, Heimo Lagler |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-12-01
|
Series: | Emerging Microbes and Infections |
Online Access: | http://link.springer.com/article/10.1038/s41426-018-0205-z |
Similar Items
-
Direct detection of Anaplasma phagocytophilum by polymerase chain reaction followed by electrospray ionization mass spectrometry from human blood
by: Heimo Lagler, et al.
Published: (2017-07-01) -
Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections
by: Matthias Karer, et al.
Published: (2020-05-01) -
Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
by: Leama Ajaka, et al.
Published: (2020-10-01) -
Hepatitis E virus seroprevalence in Austrian adults: a nationwide cross-sectional study among civilians and military professionals.
by: Heimo Lagler, et al.
Published: (2014-01-01) -
Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
by: Andy Hesketh, et al.
Published: (2021-02-01)